Ignite Creation Date:
2025-12-25 @ 4:57 AM
Ignite Modification Date:
2026-02-27 @ 12:48 AM
Study NCT ID:
NCT03208218
Status:
COMPLETED
Last Update Posted:
2017-07-06
First Post:
2017-06-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Crossover Study to Compare Pharmacokinetic Property of SYP-1512 Tab and Revlimid Cap in Healthy Male Volunteers
Sponsor:
Samyang Biopharmaceuticals Corporation
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Healthy, Male | View |